Magnesium and disturbances in carbohydrate metabolism

Diabetes, Obesity and Metabolism

Volumn 17, Issue 9, 2015, Pages 813-823

  Mooren, Frank C ^a  

^a JUSTUS LIEBIG UNIVERSITY   (Germany)

Author keywords

Glycaemic control; Hypomagnesaemia; Impaired glucose regulation; Insulin resistance; Type 2 diabetes mellitus

Indexed keywords

MAGNESIUM; GLUCOSE BLOOD LEVEL;

CARBOHYDRATE METABOLISM; DIET SUPPLEMENTATION; DISEASE ACTIVITY; DISEASE ASSOCIATION; ENERGY METABOLISM; GLYCEMIC CONTROL; HUMAN; HYPOMAGNESEMIA; IMPAIRED GLUCOSE TOLERANCE; INSULIN RELEASE; INSULIN RESISTANCE; MAGNESIUM INTAKE; MAGNESIUM METABOLISM; METABOLIC REGULATION; NON INSULIN DEPENDENT DIABETES MELLITUS; NUTRITIONAL STATUS; REVIEW; RISK FACTOR; THERAPY EFFECT; COMPLICATION; DIABETES MELLITUS, TYPE 2; DIETARY SUPPLEMENT; GLUCOSE BLOOD LEVEL; MAGNESIUM DEFICIENCY; METABOLISM; PHYSIOLOGY;

BLOOD GLUCOSE; DIABETES MELLITUS, TYPE 2; DIETARY SUPPLEMENTS; ENERGY METABOLISM; HUMANS; INSULIN RESISTANCE; MAGNESIUM; MAGNESIUM DEFICIENCY; PREDIABETIC STATE;

EID: 84939574603     PISSN: 14628902     EISSN: 14631326     Source Type: Journal    
DOI: 10.1111/dom.12492     Document Type: Review

References (102)

1. Barbagallo M, Dominguez LJ. Magnesium metabolism in type 2 diabetes mellitus, metabolic syndrome and insulin resistance. Arch Biochem Biophys 2007; 458: 40-47.
2. Romani AM. Cellular magnesium homeostasis. Arch Biochem Biophys 2011; 512: 1-23.
3. Mooren FC. Magnesium. In: Mooren FC, ed. Encyclopedia of Exercise Medicine in Health and Disease. Berlin, Heidelberg: Springer Publishers, 2012; 540-545.
4. Mooren FC, Turi S, Gunzel D etal. Calcium-magnesium interactions in pancreatic acinar cells. FASEB J 2001; 15: 659-672.
5. Günther T, Vormann J, Förster R. Regulation of intracellular magnesium by Mg2+ efflux. Biochem Biophys Res Commun 1984; 119: 124-131.
6. van der Wijst J, Bindels RJ, Hoenderop JG. Mg2+ homeostasis: the balancing act of TRPM6. Curr Opin Nephrol Hypertens 2014; 23: 361-369.
7. Thebault S, Alexander RT, Tiel Groenestege WM, Hoenderop JG, Bindels RJ. EGF increases TRPM6 activity and surface expression. J Am Soc Nephrol 2009; 20: 78-85.
8. Jakob A, Becker J, Schöttli G, Fritzsch G. Alpha 1-adrenergic stimulation causes Mg2+ release from perfused rat liver. FEBS Lett 1989; 246: 127-130.
9. 2+ content enhances hexose 6-phosphate dehydrogenase activity and expression in HepG2 and HL-60 cells. Arch Biochem Biophys 2014; 548: 11-19.
10. Yan J, Lawson JE, Reed LJ. Role of the regulatory subunit of bovine pyruvate dehydrogenase phosphatase. Proc Natl Acad Sci U S A 1996; 93: 4953-4956.
11. Feldkamp T, Park JS, Pasupulati R etal. Regulation of the mitochondrial permeability transition in kidney proximal tubules and its alteration during hypoxia-reoxygenation. Am J Physiol Renal Physiol 2009; 297: F1632-1646.
12. Crescenzo R, Bianco F, Mazzoli A, Giacco A, Liverini G, Iossa S. Mitochondrial efficiency and insulin resistance. Front Physiol 2015; 5: 512.
13. Mogensen M, Sahlin K, Fernström M etal. Mitochondrial respiration is decreased in skeletal muscle of patients with type 2 diabetes. Diabetes 2007; 56: 1592-1599.
14. Pradhan RK, Qi F, Beard DA, Dash RK. Characterization of Mg2+ inhibition of mitochondrial Ca2+ uptake by a mechanistic model of mitochondrial Ca2+ uniporter. Biophys J 2011; 101: 2071-2081.
15. Suárez A, Pulido N, Casla A, Casanova B, Arrieta FJ, Rovira A. Impaired tyrosine-kinase activity of muscle insulin receptors from hypomagnesaemic rats. Diabetologia 1995; 38: 1262-1270.
16. Rodríguez-Morán M, Guerrero-Romero F. Insulin secretion is decreased in non-diabetic individuals with hypomagnesaemia. Diabetes Metab Res Rev 2011; 27: 590-596.
17. Guerrero-Romero F, Rodríguez-Morán M. Magnesium improves the beta-cell function to compensate variation of insulin sensitivity: double-blind, randomized clinical trial. Eur J Clin Invest 2011; 41: 405-410.
18. Guerrero-Romero F, Rodríguez-Morán M. Low serum magnesium levels and metabolic syndrome. Acta Diabetol 2002; 39: 209-213.
19. Guerrero-Romero F, Rodríguez-Morán M. Hypomagnesemia, oxidative stress, inflammation, and metabolic syndrome. Diabetes Metab Res Rev 2006; 22: 471-476.
20. Lima Mde L, Cruz T, Rodrigues LE etal. Serum and intracellular magnesium deficiency in patients with metabolic syndrome-evidences for its relation to insulin resistance. Diabetes Res Clin Pract 2009; 83: 257-262.
21. Evangelopoulos AA, Vallianou NG, Panagiotakos DB etal. An inverse relationship between cumulating components of the metabolic syndrome and serum magnesium levels. Nutr Res 2008; 28: 659-663.
22. Liu ZM, Ho SC. The association of serum C-reactive protein, uric acid and magnesium with insulin resistance in Chinese postmenopausal women with prediabetes or early untreated diabetes. Maturitas 2011; 70: 176-181.
23. Yu Y, Cai Z, Zheng J etal. Serum levels of polyunsaturated fatty acids are low in Chinese men with metabolic syndrome, whereas serum levels of saturated fatty acids, zinc, and magnesium are high. Nutr Res 2012; 32: 71-77.
24. Dibaba DT, Xun P, Fly AD, Yokota K, He K. Dietary magnesium intake and risk of metabolic syndrome: a meta-analysis. Diabet Med 2014; 31: 1301-1309.
25. Huang JH, Lu YF, Cheng FC, Lee JN, Tsai LC. Correlation of magnesium intake with metabolic parameters, depression and physical activity in elderly type 2 diabetes patients: a cross-sectional study. Nutr J 2012; 11: 41.
26. Hruby A, Ngwa JS, Renström F etal. Higher magnesium intake is associated with lower fasting glucose and insulin, with no evidence of interaction with select genetic loci, in a meta-analysis of 15 CHARGE Consortium Studies. J Nutr 2013; 143: 345-353.
27. Guerrero-Romero F, Rascón-Pacheco RA, Rodríguez-Morán M, de la Peña JE, Wacher N. Hypomagnesaemia and risk for metabolic glucose disorders: a 10-year follow-up study. Eur J Clin Invest 2008; 38: 389-396.
28. Noori N, Nafar M, Poorrezagholi F etal. Dietary intakes of fiber and magnesium and incidence of metabolic syndrome in first year after renal transplantation. J Ren Nutr 2010; 20: 101-111.
29. Hruby A, Meigs JB, O'Donnell CJ, Jacques PF, McKeown NM. Higher magnesium intake reduces risk of impaired glucose and insulin metabolism and progression from prediabetes to diabetes in middle-aged Americans. Diabetes Care 2014; 37: 419-427.
30. He K, Liu K, Daviglus ML etal. Magnesium intake and incidence of metabolic syndrome among young adults. Circulation 2006; 113: 1675-1682.
31. Beckett AG, Lewis JG. Serum magnesium in diabetes mellitus. Clin Sci 1959; 18: 597-604.
32. Masood N, Baloch GH, Ghori RA, Memon IA, Memon MA, Memon MS. Serum zinc and magnesium in type-2 diabetic patients. J Coll Physicians Surg Pak 2009; 19: 483-486.
33. Zargar AH, Shah NA, Masoodi SR etal. Copper, zinc, and magnesium levels in non-insulin dependent diabetes mellitus. Postgrad Med J 1998; 74: 665-668.
34. Barbagallo M, Di Bella G, Brucato V etal. Serum ionized magnesium in diabetic older persons. Metabolism 2014; 63: 502-509.
35. Corica F, Allegra A, Ientile R etal. Reduced intraplatelet magnesium concentrations in elderly patients with non-insulin dependent diabetes mellitus (NIDDM). Arch Gerontol Geriatr 1997; 25: 255-262.
36. Crook M, Couchman S, Tutt P, Amiel S, Swaminathan R. Erythrocyte, plasma total, ultrafiltrable and platelet magnesium in type 2 (non-insulin dependent) diabetes mellitus. Diabetes Res 1994; 27: 73-79.
37. Afridi HI, Kazi TG, Kazi N etal. Potassium, calcium, magnesium, and sodium levels in biological samples of hypertensive and nonhypertensive diabetes mellitus patients. Biol Trace Elem Res 2008; 124: 206-224.
38. Xu J, Xu W, Yao H, Sun W, Zhou Q, Cai L. Associations of serum and urinary magnesium with the pre-diabetes, diabetes and diabetic complications in the Chinese Northeast population. PLoS One 2013; 8: e56750.
39. Ferdousi S, Mia AR, Mahzabeen L, Nath RK, Mollah FH. Serum zinc and magnesium level in newly diagnosed type-2 diabetic subjects. Mymensingh Med J 2013; 22: 552-556.
40. Lecube A, Baena-Fustegueras JA, Fort JM, Pelegrí D, Hernández C, Simó R. Diabetes is the main factor accounting for hypomagnesemia in obese subjects. PLoS One 2012; 7: e30599.
41. Håglin L, Bäckman L, Törnkvist B. A structural equation model for assessment of links between changes in serum triglycerides, -urate, and -glucose and changes in serum calcium, -magnesium and -phosphate in type 2 diabetes and non-diabetes metabolism. Cardiovasc Diabetol 2011; 10: 116.
42. Viktorínová A, Toserová E, Krizko M, Duracková Z. Altered metabolism of copper, zinc, and magnesium is associated with increased levels of glycated hemoglobin in patients with diabetes mellitus. Metabolism 2009; 58: 1477-1482.
43. Simmons D, Joshi S, Shaw J. Hypomagnesaemia is associated with diabetes: not pre-diabetes, besity or the metabolic syndrome. Diabetes Res Clin Pract 2010; 87: 261-266.
44. Chambers EC, Heshka S, Gallagher D, Wang J, Pi-Sunyer FX, Pierson RN Jr. Serum magnesium and type-2 diabetes in African Americans and Hispanics: a New York cohort. J Am Coll Nutr 2006; 25: 509-513.
45. Al-Osali ME, Al-Qassabi SS, El Sayed MK. Hypomagnesemia in type 2 diabetic Omani patients. Saudi Med J 2009; 30: 897-901.
46. Wälti MK, Zimmermann MB, Spinas GA, Hurrell RF. Low plasma magnesium in type 2 diabetes. Swiss Med Wkly 2003; 133: 289-292.
47. Wang JL, Shaw NS, Yeh HY, Kao MD. Magnesium status and association with diabetes in the Taiwanese elderly. Asia Pac J Clin Nutr 2005; 14: 263-269.
48. Srivastava VK, Chauhan AK, Lahiri VL. The significance of serum magnesium in diabetes mellitus. Indian J Med Sci 1993; 47: 119-123.
49. Ma J, Folsom AR, Melnick SL etal. Associations of serum and dietary magnesium with cardiovascular disease, hypertension, diabetes, insulin, and carotid arterial wall thickness: the ARIC study. Atherosclerosis Risk in Communities Study. J Clin Epidemiol 1995; 48: 927-940.
50. Isbir T, Tamer L, Taylor A, Isbir M. Zinc, copper and magnesium status in insulin-dependent diabetes. Diabetes Res 1994; 26: 41-45.
51. Mather HM, Nisbet JA, Burton GH etal. Hypomagnesaemia in diabetes. Clin Chim Acta 1979; 95: 235-242.
52. Seyoum B, Siraj ES, Saenz C, Abdulkadir J. Hypomagnesemia in Ethiopians with diabetes mellitus. Ethn Dis 2008; 18: 147-151.
53. Corica F, Ientile R, Allegra A etal. Magnesium levels in plasma, erythrocyte, and platelet in hypertensive and normotensive patients with type 2 diabetes mellitus. Biol Trace Elem Res 1996; 51: 13-21.
54. Corsonello A, Ientile R, Buemi M etal. Serum ionized magnesium levels in type 2 diabetic patients with microalbuminuria or clinical proteinuria. Am J Nephrol 2000; 20: 187-192.
55. Millart H, Durlach V, Durlach J. Red blood cell magnesium concentrations: analytical problems and significance. Magnes Res 1995; 8: 65-76.
56. Külpmann WR, Gerlach M. Relationship between ionized and total magnesium in serum. Scand J Clin Lab Invest Suppl 1996; 224: 251-258.
57. Dong JY, Xun P, He K, Qin LQ. Magnesium intake and risk of type 2 diabetes: meta-analysis of prospective cohort studies. Diabetes Care 2011; 34: 2116-2122.
58. Hata A, Doi Y, Ninomiya T etal. Magnesium intake decreases Type 2 diabetes risk through the improvement of insulin resistance and inflammation: the Hisayama study. Diabet Med 2013; 30: 1487-1494.
59. Kao WH, Folsom AR, Nieto FJ, Mo JP, Watson RL, Brancati FL. Serum and dietary magnesium and the risk for type 2 diabetes mellitus: the Atherosclerosis Risk in Communities Study. Arch Intern Med 1999; 159: 2151-2159.
60. Everett CJ, King DE. Serum magnesium and the development of diabetes. Nutrition 2006; 22: 679.
61. Pham PC, Pham PA, Pham SV, Pham PT, Pham PM, Pham PT. Hypomagnesemia: a clinical perspective. Int J Nephrol Renovasc Dis 2014; 7: 219-230.
62. Song Y, Hsu YH, Niu T, Manson JE, Buring JE, Liu S. Common genetic variants of the ion channel transient receptor potential membrane melastatin 6 and 7 (TRPM6 and TRPM7), magnesium intake, and risk of type 2 diabetes in women. BMC Med Genet 2009; 10: 4.
63. Sharma A, Dabla S, Agrawal RP, Barjatya H, Kochar DK, Kothari RP. Serum magnesium: an early predictor of course and complications of diabetes mellitus. J Indian Med Assoc 2007; 105: 16-20.
64. Srinivasan AR, Niranjan G, Kuzhandai Velu V, Parmar P, Anish A. Status of serum magnesium in type 2 diabetes mellitus with particular reference to serum triacylglycerol levels. Diabetes Metab Syndr 2012; 6: 187-189.
65. Dasgupta A, Sarma D, Saikia UK. Hypomagnesemia in type 2 diabetes mellitus. Indian J Endocrinol Metab 2012; 16: 1000-1003.
66. Sakaguchi Y, Shoji T, Hayashi T etal. Hypomagnesemia in type 2 diabetic nephropathy: a novel predictor of end-stage renal disease. Diabetes Care 2012; 35: 1591-1597.
67. Håglin L, Törnkvist B, Bäckman L. Prediction of all-cause mortality in a patient population with hypertension and type 2 DM by using traditional risk factors and serum-phosphate, -calcium and-magnesium. Acta Diabetol 2007; 44: 138-143.
68. Peters KE, Chubb SA, Davis WA, Davis TM. The relationship between hypomagnesemia, metformin therapy and cardiovascular disease complicating type 2 diabetes: the Fremantle Diabetes Study. PLoS One 2013; 8: e74355.
69. Wang S, Hou X, Liu Y etal. Serum electrolyte levels in relation to macrovascular complications in Chinese patients with diabetes mellitus. Cardiovasc Diabetol 2013; 12: 146.
70. Del Gobbo LC, Song Y, Poirier P, Dewailly E, Elin RJ, Egeland GM. Low serum magnesium concentrations are associated with a high prevalence of premature ventricular complexes in obese adults with type 2 diabetes. Cardiovasc Diabetol 2012; 11: 23.
71. Kisters K, Gröber U. Magnesium in health and disease. Plant Soil 2013; 368: 155-165.
72. Mursu J, Nurmi T, Voutilainen S, Tuomainen TP, Virtanen JK. The association between serum 25-hydroxyvitamin D3 concentration and risk of disease death in men: modification by magnesium intake. Eur J Epidemiol 2015; 30: 343-347.
73. Guerrero-Romero F, Tamez-Perez HE, González-González G etal. Oral magnesium supplementation improves insulin sensitivity in non-diabetic subjects with insulin resistance. A double-blind placebo-controlled randomized trial. Diabetes Metab 2004; 30: 253-258.
74. Lee S, Park HK, Son SP etal. Effects of oral magnesium supplementation on insulin sensitivity and blood pressure in normo-magnesemic nondiabetic overweight Korean adults. Nutr Metab Cardiovasc Dis 2009; 19: 781-788.
75. Chacko SA, Sul J, Song Y etal. Magnesium supplementation, metabolic and inflammatory markers, and global genomic and proteomic profiling: a randomized, double-blind, controlled, crossover trial in overweight individuals. Am J Clin Nutr 2011; 93: 463-473.
76. Hadjistavri LS, Sarafidis PA, Georgianos PI etal. Beneficial effects of oral magnesium supplementation on insulin sensitivity and serum lipid profile. Med Sci Monit 2010; 16: CR307-312.
77. Mooren FC, Krüger K, Völker K, Golf SW, Wadepuhl M, Kraus A. Oral magnesium supplementation reduces insulin resistance in non-diabetic subjects - a double-blind, placebo-controlled, randomized trial. Diabetes Obes Metab 2011; 13: 281-284.
78. Rodríguez-Moran M, Guerrero-Romero F. Oral magnesium supplementation improves the metabolic profile of metabolically obese, normal-weight individuals: a randomized double-blind placebo-controlled trial. Arch Med Res 2014; 45: 388-393.
79. Simental-Mendía LE, Rodríguez-Morán M, Guerrero-Romero F. Oral magnesium supplementation decreases C-reactive protein levels in subjects with prediabetes and hypomagnesemia: a clinical randomized double-blind placebo-controlled trial. Arch Med Res 2014; 45: 325-330.
80. Lima de Souza E Silva Mde L, Cruz T, Rodrigues LE etal. Magnesium replacement does not improve insulin resistance in patients with metabolic syndrome: a 12-week randomized double-blind study. J Clin Med Res 2014; 6: 456-462.
81. Coudray C, Rambeau M, Feillet-Coudray C etal. Study of magnesium bioavailability from ten organic and inorganic Mg salts in Mg-depleted rats using a stable isotope approach. Magnes Res 2005; 18: 215-223.
82. Paolisso G, Sgambato S, Pizza G, Passariello N, Varricchio M, D'Onofrio F. Improved insulin response and action by chronic magnesium administration in aged NIDDM subjects. Diabetes Care 1989; 12: 265-269.
83. Paolisso G, Scheen A, Cozzolino D etal. Changes in glucose turnover parameters and improvement of glucose oxidation after 4-week magnesium administration in elderly noninsulin-dependent (type 2) diabetic patients. J Clin Endocrinol Metab 1994; 78: 1510-1514.
84. Gullestad L, Jacobsen T, Dolva LO. Effect of magnesium treatment on glycemic control and metabolic parameters in NIDDM patients. Diabetes Care 1994; 17: 460-461.
85. Purvis JR, Cummings DM, Landsman P etal. Effect of oral magnesium supplementation on selected cardiovascular risk factors in non-insulin-dependent diabetics. Arch Fam Med 1994; 3: 503-508.
86. Corica F, Allegra A, Di Benedetto A etal. Effects of oral magnesium supplementation on plasma lipid concentrations in patients with non-insulin-dependent diabetes mellitus. Magnes Res 1994; 7: 43-47.
87. Eibl NL, Kopp HP, Nowak HR, Schnack CJ, Hopmeier PG, Schernthaner G. Hypomagnesemia in type 2 diabetes: effect of a 3-month replacement therapy. Diabetes Care 1995; 18: 188-192.
88. Eriksson J, Kohvakka A. Magnesium and ascorbic acid supplementation in diabetes mellitus. Ann Nutr Metab 1995; 39: 217-223.
89. de Lordes Lima M, Cruz T, Pousada JC, Rodrigues LE, Barbosa K, Canguçu V. The effect of magnesium supplementation in increasing doses on the control of type 2 diabetes. Diabetes Care 1998; 21: 682-686.
90. de Valk HW, Verkaaik R, van Rijn HJ, Geerdink RA, Struyvenberg A. Oral magnesium supplementation in insulin-requiring type 2 diabetic patients. Diabet Med 1998; 15: 503-507.
91. Rodríguez-Morán M, Guerrero-Romero F. Oral magnesium supplementation improves insulin sensitivity and metabolic control in type 2 diabetic subjects: a randomized double-blind controlled trial. Diabetes Care 2003; 26: 1147-1152.
92. Guerrero-Romero F, Rodríguez-Morán M. The effect of lowering blood pressure by magnesium supplementation in diabetic hypertensive adults with low serum magnesium levels: a randomized, double-blind, placebo-controlled clinical trial. J Hum Hypertens 2009; 23: 245-251.
93. Barbagallo M, Dominguez LJ, Galioto A, Pineo A, Belvedere M. Oral magnesium supplementation improves vascular function in elderly diabetic patients. Magnes Res 2010; 23: 131-137.
94. Navarrete-Cortes A, Ble-Castillo JL, Guerrero-Romero F etal. No effect of magnesium supplementation on metabolic control and insulin sensitivity in type 2 diabetic patients with normomagnesemia. Magnes Res 2014; 27: 48-56.
95. Solati M, Ouspid E, Hosseini S, Soltani N, Keshavarz M, Dehghani M. Oral magnesium supplementation in type 2 diabetic patients. Med J Islam Repub Iran 2014; 28: 67.
96. Farruggia G, Castiglioni S, Sargenti A etal. Effects of supplementation with different Mg salts in cells: is there a clue? Magnes Res 2014; 27: 25-34.
97. Ye J. Mechanisms of insulin resistance in obesity. Front Med 2013; 7: 14-24.
98. Institute of Medicine (IOM). Food and Nutrition Board. Dietary Reference Intakes: Calcium, Phosphorus, Magnesium, Vitamin D and Fluoride. Washington: National Academy Press, 1997.
99. Evert AB, Boucher JL, Cypress M etal. Nutrition therapy recommendations for the management of adults with diabetes. Diabetes Care 2013; 36: 3821-3842.
100. von Ehrlich B, Barbagallo M, Classen HG etal. The significance of magnesium in insulin resistance, metabolic syndrome and diabetes - recommendations of the association of magnesium research e. V. Diabetol Stoffwechselkr 2014; 2: 96-100.
101. Kobayashi T. Plasma and erythrocyte magnesium levels are correlated with oxygen uptake in patients with non-insulin dependent diabetes mellitus. Endocr J 1998; 45: 277-283.
102. Regensteiner JG, Sippel J, McFarling ET, Wolfel EE, Hiatt WR. Effects of non-insulin-dependent diabetes on oxygen consumption during treadmill exercise. Med Sci Sports Exerc 1995; 27: 875-881.